Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial
Michael C. Tanner(Heidelberg University), Patrick Haubruck(Heidelberg University), Thomas Ferbert(Heidelberg University), Simone Gantz(Heidelberg University), Matthias Miska(Heidelberg University), Christian Fischer(VIB-KU Leuven Center for Cancer Biology), Raban Heller(Bundeswehrkrankenhaus), Gerhard Schmidmaier(Heidelberg University), Fabian Westhauser(Heidelberg University)
Cited by 23
Related Papers
Selenium Deficiency Is Associated with Mortality Risk from COVID-19
|Nutrients|2020|362
Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
|Redox Biology|2020|181
Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties
|Cancer Cell|2013|146
Selenium Deficiency is Associated with Mortality Risk from COVID-19
|Preprints.org|2020|88